|
|
Volumn 5, Issue 12, 1996, Pages 1657-1671
|
|
Current perspectives on the treatment and prevention of hepatitis C infection
a
|
|
Author keywords
alpha interferon; hepatitis C infection; hepatitis C vaccine; ribavirin
|
|
Indexed keywords
ALPHA INTERFERON;
ALPHAN1 INTERFERON;
ALPHAN3 INTERFERON;
ANTIVIRUS AGENT;
BETA INTERFERON;
CARBOXYETHYLGERMANIUM SESQUIOXIDE;
CONSENSUS INTERFERON;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HEPATITIS C VACCINE;
HEPATITIS VACCINE;
IMMUNOMODULATING AGENT;
INTERLEUKIN 2;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEGA INTERFERON;
PROTEINASE INHIBITOR;
RIBAVIRIN;
THERADIGM HCV;
THYMOSIN;
THYMOSIN ALPHA1;
UNCLASSIFIED DRUG;
URSODEOXYCHOLIC ACID;
CHRONIC HEPATITIS;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG RESPONSE;
HEPATITIS C;
HEPATITIS C VIRUS;
HOST RESISTANCE;
HUMAN;
IMMUNE RESPONSE;
LICENCE;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
NONHUMAN;
PUBLIC HEALTH;
REVIEW;
VIRUS REPLICATION;
|
|
EID: 0030457708
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.12.1657 Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
